Patent details
301204
Product Name:
onasemnogene abeparvovec
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
301204
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP3505635
Status:
Application Pending
Application number:
301204
Procedural language:
Dutch
First Applicant Residence Country:
France (FR)
Marketing Authorization
Marketing Authorization Number:
EU/1/20/1443
Marketing Authorization Type:
EEA
Marketing Authorization Date:
18/05/2020
Marketing Authorization Country:
European Union (EU)
Dates
Filing date:
18/11/2022
First Marketing Authorization date:
18/05/2020
Grant date:
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
18/11/2022
SPC/SPC Extension Expiration Date:
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
Applicant/holder
From:
18/11/2022
Name:
Genethon
Address:
1 bis rue de l'Internationale, 91000 Evry, France (FR)
From:
18/11/2022
Name:
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
Address:
3, rue Michel Ange, 75016 Paris, France (FR)
Agent
1
Name:
ir. B.Ch. Ledeboer c.s
From:
09/01/2025
Address:
V.O.
Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:
2
Name:
ir. H.A. Witmans c.s.
From:
18/11/2022
Address:
V.O.
Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:
09/01/2025
Publication
Bulletin
Bulletin Heading:
SPC
Journal edition number:
47/22
Publication date:
23/11/2022
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Filing date
Document type
Document Description
Number of pages
File Type
22/11/2022
Outgoing Correspondence
Confirmation receipt request
1
PDF
/2/9/3/7/3/0800837392/docs/301204_0_515695l174.pdf
18/11/2022
Application Form
First filed application form
3
PDF
/2/9/3/7/3/0800837392/docs/301204_1_applicationform20221118042836482.pdf
18/11/2022
SPC Documents
Accompanying letter SPC
1
PDF
/2/9/3/7/3/0800837392/docs/301204_2_supplprotectioncertificate20221118042836563.pdf
18/11/2022
SPC Documents
Marketing Authorization SPC
3
PDF
/2/9/3/7/3/0800837392/docs/301204_3_supplprotectioncertificate20221118042836609.pdf
18/11/2022
SPC Documents
Summary of the characteristics of the product
19
PDF
/2/9/3/7/3/0800837392/docs/301204_4_supplprotectioncertificate20221118042836636.pdf
18/11/2022
SPC Documents
Annex SPC
3
PDF
/2/9/3/7/3/0800837392/docs/301204_5_supplprotectioncertificate20221118042836664.pdf
18/11/2022
SPC Documents
Annex SPC
18
PDF
/2/9/3/7/3/0800837392/docs/301204_6_supplprotectioncertificate20221118042836694.pdf
18/11/2022
SPC Documents
Annex SPC
2
PDF
/2/9/3/7/3/0800837392/docs/301204_7_supplprotectioncertificate20221118042836719.pdf